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ABSTRACT 
 
Aim: The centralisation of oesophago-gastric (O-G) cancer services in England was 
recommended in 2001, partly because of evidence for a volume-outcome effect for patients 
having surgery. This study investigated the changes in surgical services for O-G cancer and 
postoperative mortality since centralisation  
Methods: Patients with O-G cancer who had an oesophageal or gastric resection between 
April 2003 and March 2014 were identified in the national Hospital Episodes Statistics 
database.  We derived information on the number of NHS trusts performing surgery, their 
surgical volume, and the number of consultants operating.  Postoperative  mortality was 
measured at 30 days, 90 days and 1 year. Logistic regression was used to examine how 
surgical outcomes were related to patient characteristics and organisational variables. 
Results: During this period, 29 205 patients underwent an oesophagectomy or gastrectomy. 
The number of NHS trusts performing surgery decreased from 113 in 2003-04 to 43 in 2013-
14, and the median annual surgical volume in NHS trusts rose from 21 to 55 patients.  The 
annual 30 day, 90 day and 1 year mortality decreased from 7.4%, 11.3% and 29.7% in 2003-
04 to 2.5%, 4.6% and 19.8% in 2013-14, respectively. There was no evidence that high-risk 
patients were not undergoing surgery.  Changes in NHS trust volume explained only a small 
proportion of the observed fall in mortality.  
Conclusion: Centralisation of surgical services for O-G cancer in England has resulted in 
lower postoperative mortality. This cannot be explained by increased volume alone. 
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INTRODUCTION 
In 2001, the UK Department of Health published guidance on the commissioning of health 
care for patients with oesophago-gastric (O-G) cancer [1].  It contained a number of 
recommendations that would require a major restructuring of NHS services.  First, it 
recommended that cancer networks should be established, with specialist hospitals within 
each network responsible for performing curative surgery and specialist diagnostic tests 
(cancer centres). Other hospitals in the Network would continue to provide routine diagnostic 
investigations and palliative services (cancer units).  Second, it recommended that clinicians 
from different specialties (eg, upper gastrointestinal surgeon, gastroenterologist, oncologist, 
radiologist, pathologist and clinical nurse specialist) should work together in multi-
disciplinary teams, in order to improve the coordination of clinical management.  The 
National Cancer Peer Review Programme was established in 2004 to monitor implementation 
of these organisation changes [2].  The National Oesophago-Gastric Cancer Audit has 
complemented this by assessing whether O-G cancer services meet the relevant standards of 
care as measured against various process and outcomes indicators [3].  
One rationale for centralisation was the thought that expanding the volume and variety of 
cases treated in larger cancer centres would address apparent regional inequalities in life 
expectancy [1,4].  This was partly underpinned by an increasing number of international 
studies that showed a volume-outcome relationship in O-G cancer surgery [5-8]. Moreover, 
this relationship was observed across O-G cancer services in England between 2004 and 2008 
by Coupland et al [9]. They reported that increasing hospital volume was strongly associated 
with lower postoperative mortality at 30 days.   
This study was designed to investigate the changes in surgical activity and outcomes that have 
occurred over the eleven year period from April 2003 to March 2014.  The reorganisation of 
O-G cancer services was still ongoing during 2004 and 2008 [10] and it is unclear how this 
might have influenced the results describing the period between 2003 and 2013.  In addition, 
since 2001, there have also been many improvements in areas of diagnosis, pre-operative 
staging, peri-operative care, and the introduction of neoadjuvant and adjuvant oncology [11]. 
In this study, we examined trends in (i) the numbers of NHS trusts performing curative 
surgery, (ii) the median patient volume of these trusts, (iii) the number of consultants 
performing surgery, and how these might be associated with changes in postoperative 
mortality after surgical resection at 30 days, 90 days and 1 year. 
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METHODS 
Data source 
Data on the inpatient care received by patients with O-G cancer in English NHS trusts was 
obtained from Hospital Episodes Statistics (HES), a hospital administrative database that 
contains records on all same day and overnight admissions to English NHS acute trusts.  
Clinical information is captured using the International Classification of Disease (ICD-10) 
diagnostic codes and the Classification of Surgical Operations and Procedures (OPCS-4), but 
it lacks specific information about tumour characteristics (such as pathological stage) and 
cancer care (such as date of diagnosis).  Records for the same individual are allocated the 
same anonymised identifier, which allows treatment pathways to be followed over time. 
Patient cohort and characteristics 
We identified all patients (aged 18 years and over) diagnosed with oesophageal or stomach 
cancer (ICD-10: C15 and C16) between 1 April 2003 and 31 March 2014, taking the first 
instance of these codes as the date of diagnosis. Variables were defined for patient age at 
diagnosis, sex, tumour type (oesophageal / stomach), and number of comorbidities. 
Comorbidities were identified using the RCS Charlson score [12], which covers 14 conditions 
known to be associated with the risk of postoperative mortality (the score includes categories 
for malignancy and metastatic tumours, and these were excluded when calculating the score 
in this study).  Patients were labelled as having 0, 1, 2, and 3 or more comorbidities.  A 
variable for socioeconomic deprivation was also defined using the 2004 Index of Multiple 
deprivation (IMD) [13]. We categorised the IMD score into ordered quintiles, with the first 
and  fifth quintiles corresponding to the least and most deprived, respectively.  
Services and treatments at NHS hospitals 
Patients were flagged as having curative surgery if they underwent either oesophagectomy or 
gastrectomy (OPCS codes: G01, G02, G03-oseophageal resections; G27, G28-gastric 
resections).  We flagged an NHS trust as performing curative surgery if it had performed 
more than five procedures in a financial year (April-March).  Individual consultants were 
identified using the anonymised consultant code, and were counted as part of the O-G surgical 
team within an NHS trust if they had performed at least one operation in a year.  The 
consultant codes were available from the 2005-06 financial year.  Surgical volume at NHS 
trust and consultant level was defined as the total number of procedures performed in the 
financial year.   
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Over the study period, there was an increase in the combination of neoadjuvant chemotherapy 
and radiotherapy with surgery.  As inpatient HES records do not capture information about 
the provision of chemo/radiotherapy reliably, we used the time from diagnosis to surgery as a 
proxy marker for a patient having neoadjuvant therapy (Appendix, Figure A).  If the time 
from diagnosis to surgery was greater than 100 days, a patient was flagged as having 
neoadjuvant therapy and surgery; otherwise, they were flagged as having surgery alone. 
 
Outcome variables  
The primary outcomes were postoperative mortality at 30 days, 90 days or 1 year and was 
calculated for each patient as the difference between the date of operation and date of death.  
The date of death was obtained from the Office for National Statistics Death Register, with 
patients identified using the same anonymised HESID used within the HES database. Dates of 
death were available until 16 October 2016, hence all patients had a minimum of 1 year 
follow up information .  Length of postoperative hospital stay was defined as a secondary 
outcome and calculated as the difference between operation date and the discharge date. 
 
Statistical analysis 
For each financial year, we derived the number of NHS trusts undertaking  curative surgery, 
the number of consultants per NHS trust performing surgery, the annual number of operations 
performed at a trust, and the number of patients having surgery.  The financial years were 
labelled as the year in which they begin. 
Patient characteristics were described using proportions, with continuous variables being 
categorised to show the skewness of the distributions.  The analysis was undertaken using 
year of operation.  We grouped the data into periods for presentation only. The association 
between year of operation and  categorical variables were assessed using chi-squared tests, 
and the association between year of operation and continuous variables were assessed using 
linear regression where the year of operation was defined as a linear term.  
Logistic regression models were used to examine the association between postoperative 
mortality (at 30 day, 90 day and 1 year), trust volume, and patient variables (age, sex, type of 
cancer, comorbidities, social deprivation, and whether or not a patient was flagged as having 
neoadjuvant therapy).  Estimates were derived with robust standard errors to account for the 
clustering of patients within NHS trusts.  
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Adjusted mortality rates for each financial year were derived by dividing the observed deaths 
by the number expected multiplied by the mean rate over the study period. A predicted risk of 
death for each patient was derived from multivariable logistic regression models and summed 
up for each year to create the expected number [14]. All statistical tests were two-sided, with 
p-values of less than 0.05 indicating a significant result. The analyses were performed using 
STATA® version 14 (StataCorp, College Station, Texas, USA).  
 
RESULTS  
 
Changes in trust and consultant volumes 
Between financial years 2003-04 and 2013-14, a total of 139 724  patients were diagnosed 
with O-G cancer in English NHS trusts.  Of these, 29 205 patients (20.9%) had an 
oesophagectomy or gastrectomy.  The number of operations per year typically fluctuated 
between 2500 and 2900, with no obvious change in overall annual surgical activity.  
However, there was a steady decline in the number of NHS trusts performing curative surgery 
and an increase in the median volume of patients having surgery at NHS trusts as the process 
of centralisation was rolled out (Figure 1).  In 2003-04, there were 113 NHS trusts performing 
surgery, which had declined to 43 in 2013-14.  There was a corresponding increase in median 
annual surgical volume at NHS trusts over this period (from 21 in 2003-04 to 55 in 2013-14), 
with the principal period of change occurring between financial years 2006-07 and 2010-11 
(see Figure 1).  The impact of these changes for patients is illustrated in Figure B (Appendix).  
In 2003-04, around 40% of patients had their procedure at a cancer centre with an annual 
activity at least 40 cases; in 20013-14, over 85% of patients had their procedure at a cancer 
centre with at least this volume, and 32% of patients had surgery at a centre with an annual 
volume above 80. 
Although the cancer centres more than doubled their median numbers of operations over the 
11 year period, there was less change in the annual case volumes among consultants.  The 
median increased from 11 in 2005-06 to 14 in 2013-14, which reflected the increase in the 
number of consultant surgeons working within each NHS trust. In 2005-06, 44.1% centres 
(41/93) had teams of two surgeons, but by 2013-14, 88.4% centres trusts (38/43) had three or 
more surgeons (see Table 1 in Appendix for full details).   
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Outcomes in length of stay and postoperative mortality 
The unadjusted rates of 30 day, 90 day, and 1 year postoperative mortality for operations 
performed each financial year are shown in Figure 2.  Our results show that both 30 day and 
90 day, mortality decreased significantly, from 7.4% and 11.3 % in 2003-04 to 2.5% and 
4.6% in 2013-14, respectively.  One year mortality decreased from 29.7% to 19.8%.  A 
sensitivity analysis using segmented regression did not find statistical evidence for any 
changes in the speed of decline over the study period for the three mortality rates (results not 
shown). 
 
Over the same time period, there was also a small reduction in the average postoperative 
length of stay, with the mean (SD) falling from 16.9 (12.3) days in 2003-04 to 14.8 (12.2) 
days in 2013-14 (p-value <0.001).  
 
Profile of patient characteristics 
Table 1 shows the characteristics of patients who had  curative surgery over the study period.   
For both oesophageal and gastric cancer patients, patients undergoing surgery as a proportion 
of all patients diagnosed decreased with increasing age and was lower among women 
compared to men (Table 1).   Although the quality of coding of co-morbidities has improved 
with time, there is no evidence to suggest that patients with more co-morbidities were less 
likely to have surgery.   
The change in the organisation of surgery did not appear to have resulted in large changes in 
the characteristics of patients being selected for surgery (Table 1).  Over time, the proportions 
of patients having surgery remained stable across the age categories, by gender, and for 
increasing numbers of comorbidities.  The distribution of surgical patients with oesophageal 
tumours across the deprivation quintiles was also little changed.  
 
Relationship between outcomes and other factors  
Table 2 shows the odds ratios for the annual change in mortality, relative to the baseline of 
2003/04 for 30 day, 90 day and 1 year mortality. The table describes the effect of, first, 
adjusting for patient characteristics (partial model) and, second, adjusting for patient 
characteristics, trust volume and time to surgery (complete model).  In the models for all three 
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outcomes, higher mortality was associated with increasing age, oesophageal tumours 
(compared to stomach), and increasing number of comorbidities.  In the complete model, an 
increase in 5 cases was associated with lower 30 and 90 day mortality (adjusted OR = 0.97 
and 0.98, respectively) but not with 1-year mortality (adjusted OR = 1.0).  The adjustment for 
these factors, however, did not explain much of the downward trend in mortality.  Year on 
year, there was still an 11% reduction in 30 day mortality, 10% reduction in 90 day mortality 
and 6% reduction in 1 year mortality.  This can be seen in Figure 3, which shows the adjusted 
90 day mortality rate (patient characteristics only-partially adjusted model ) alongside the 90 
day mortality rate adjusted for patient characteristics, time to surgery and NHS trust volume 
(fully adjusted model) . A similar pattern was seen with adjusted graphs of 30 day and 1 year 
mortality.  
 
 
DISCUSSION  
This study investigated the changes in NHS trust volume, consultant numbers, and clinical 
practice since the policy of centralisation was introduced in England, and how these might be 
related to patterns of postoperative mortality after curative O-G cancer surgery over this 
period.    The number of NHS trusts performing surgical resections has reduced by more than 
half.  There has been a corresponding increase in surgical volume within NHS trusts, and this 
has led to a large increase in the proportion of patients having their surgery in large-volume 
centres.  This greater volume has been achieved by a rise in the number of consultants 
working within NHS trusts.  Additional surgeons were employed by the cancer centres to 
share in the specialist upper GI rota needed to provide 24 hours a day care, 365 days of the 
year for these patients.  A consequence of this was that there was only a small rise in the 
number of procedures performed by consultants each year.  The observed data on consultant 
volume suggests that only half of the current surgeons meet the minimum volumes (15-20) as 
recommended by the Association of Upper Gastrointestinal Surgeons of Great Britain and 
Ireland (AUGIS) [15].  
Our results show that postoperative mortality has improved markedly since centralisation 
began.  The annual 30 day, 90 day and 1 year mortality decreased from 7.4%, 11.3% and 
29.7% in 2003-04 to 2.5%, 4.6% and 19.8 % in 2013-14, respectively. The improvements 
were seen in both oesophageal cancer and gastric cancer when analysed separately (results not 
shown.)  This improvement did not appear to be linked to the selection of healthier cases, as 
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the age profile of patients did not change noticeably from 2003-04 to 2013-14 and there was 
no evidence that patients who underwent surgery had less comorbid disease.  The statistical 
analysis found a weak association between the change in short-term postoperative mortality 
and NHS trust volume.  However, this was unable to explain all of the observed 
improvements in outcome. 
 
Previous work and what our study adds  
Our results show that the period of centralisation of O-G cancer surgery has achieved the 
desired outcome of higher surgical volumes in NHS trusts, and that the NHS is now 
delivering better patient outcomes. Studies done at the local level in the UK support these 
high level findings but, like this study, they have been unable to disentangle the complex 
relationships between changes in hospital and surgeon volume, improvements in medical care 
(oncological treatments, staging and advances in intensive care) and patient outcomes. In 
relation to the process of care, the surgical centralisation of O-G cancer services in South East 
Wales was reported to result in a manageable workload that offered a substantial increase in 
cancer-related operative training opportunities [16]. Another study from Wales showed that 
oesophageal cancer patients treated by multi-disciplinary teams experienced a lower post-
operative mortality than control patients, and were more likely to survive 5 years (p<0.001) 
[17].  An organisational survey on the progress due to centralisation has shown that targets of 
minimum staffing levels have been achieved and the use of formal assessment of nutritional 
needs has improved [18]. In relation to the outcomes of surgery, a study examining the effect 
centralisation on O-G cancer services in Gloucester reported improvement in the median 
survival time and substantial reductions in 30 day post-operative mortality from 10.3% pre-
centralisation to 3.6% post-centralisation (p = 0.006) [19]. Experiences from abroad have 
been similar. Work conducted in the Netherlands demonstrate comparable improvements to 
those observed in our study [20].  
 
Strengths and Limitations 
The main strength of the study comes from its comprehensive coverage of all English NHS 
acute trusts.  Its principal limitations arise from the use of routine administrative hospital data.  
First, HES lacked cancer-related clinical information such as the date of cancer diagnosis.  
We used the admission date of the first O-G cancer related admission as a proxy for the date 
of diagnosis.  This will introduce some error in the time from diagnosis to surgery but it is 
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regarded as a robust method of approximation.  Second, the estimates of surgical volume rely 
on the accurate coding of oesophageal and gastric resections.  However, work comparing 
records of O-G cancer patients in HES and the National O-G cancer audit found excellent 
levels of agreement in use of the appropriate OPCS procedure codes for O-G surgical 
resection [21].   As a result, we expect the overall effect of coding errors to be small. 
Third, the HES database does not contain data on patient characteristics that could influence 
their postoperative outcome such as histology, stage of disease, and frailty [22].  The 
omission of these factors from the risk adjustment model could have reduced its explanatory 
power, but there is no evidence for these characteristics having changed greatly over study 
period.  Consequently, it seems this is unlikely to account for the observed changes in 
postoperative mortality over time.  
Finally, HES does not capture many of the changes in the organisation of services that could 
have had an impact on outcomes such as the involvement of multi-disciplinary team (MDT) 
meetings. Care under professionals with specialised knowledge and surgical expertise could 
have led to better tailored treatments. Furthermore, dedicated perioperative support, specialist 
support nurses and palliative care services might have led to better outcomes for patients [23].  
 
Conclusion 
The results of this study reveal the large change in the delivery of curative surgery to patients 
with O-G cancer between April 2003 and March 2014.  The large decrease in the number of 
NHS trusts performing surgical resections that resulted from the centralisation process shows 
that its aim of increasing the median NHS trust volumes was achieved.  The study also shows 
that a substantial reduction in postoperative mortality was also achieved over this time.  
From the steady decrease in mortality over the study period, we might expect improvements 
in patient survival to have continued since March 2014.  There is some evidence that this has 
occurred, with the National O-G Cancer Audit reporting that the postoperative mortality rate 
at 90 days for patients diagnosed between April 2014 and March 2016 was 3.3% and 3.1% for 
oesophagectomy and gastrectomy, respectively [24]. The precise reasons for these historical 
trends are unclear, however.  The process of centralisation has continued in some regions of 
England since 2014 (notably, the London and Manchester areas), but at a national level, the 
amount of organisational change has slowed.  It is important to identify the reasons for these 
historical changes in outcome so that services can use them as building blocks for further 
improvements.  
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FIGURE LEGENDS 
Figure 1: Annual numbers of trusts performing surgery and corresponding median volume of 
patients in the trusts at the national level between 2003 and 2014. Procedures are grouped by 
financial year (2003 = April 2003 – March 2004).  
Figure 2: Unadjusted rates of 30 day, 90 day and 1 year postoperative mortality between April 
2003 and March 2014. Procedures are grouped by financial year (April – March) and are 
shown with 95% confidence intervals 
Figure 3: Partially and fully adjusted annual postoperative 90-day mortality for patients with 
oesophago-gastric cancer having curative surgery between April 2003 and March 2014. 
Procedures are grouped by financial year (April – March) 
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Table 1: Characteristics of patients having surgery, as proportion of all patients diagnosed, by time period 
 Apr2003-Mar 2005 Apr2005-Mar 2008 Apr2008-Mar 2011 Apr 2011-Mar 2014 
Oesophaeal tumours (C15) 
 No of patients 3316 20.6% 4944 19.6% 5103 19.97% 5136 19.8% 
Age  group 
 Under 60 1007 32.5% 1470 31.1% 1449 31.25% 1274 29.5% 
60 to 69 1189 30.3% 1915 29.3% 2006 30.18% 2034 28.3% 
70 to 79 1007 19.6% 1395 17.9% 1471 19.03% 1609 21.1% 
80 and over 112 2.9% 163 2.6% 173 2.71% 209 3.2% 
missing  1 4.5% 1 4.0% 4 2.60% 10 4.9% 
Gender N(%), male 2534 23.6% 3766 22.2% 3975 22.55% 4026 22.3% 
Female  782 14.6% 1178 14.2% 1127 14.20% 1110 15.8% 
Missing  0 0.0% 0 0.0% 1 9.09% 0 0.0% 
Deprivation N(%) 
 1 (Least) 646 22.4% 977 21.3% 1005 21.95% 1097 22.0% 
2 690 21.6% 1115 22.0% 1153 21.67% 1153 21.8% 
3 689 20.5% 1028 19.6% 1100 20.88% 1049 19.6% 
4 610 19.1% 950 18.9% 957 19.06% 951 18.8% 
5 (Most) 618 19.4% 775 15.9% 849 17.50% 833 18.0% 
missing  63 21.6% 99 20.2% 39 7.65% 53 8.4% 
Co-morbidities N (%) 
 0 2402 18.9% 3321 17.4% 2996 16.90% 2745 16.8% 
1 752 29.1% 1246 26.9% 1590 28.61% 1725 26.5% 
2 142 22.3% 290 25.0% 406 24.68% 514 23.3% 
3 or more 20 10.9% 87 21.6% 111 17.99% 152 16.9% 
Stomach tumours (C16) 
 No of patients 2329 25.1% 3065 22.5% 2810 22.2% 2502 22.2% 
Age  group 
 Under 60 361 29.5% 544 28.5% 550 29.7% 453 27.2% 
60 to 69 613 32.4% 751 28.7% 673 29.6% 609 29.7% 
70 to 79 960 29.4% 1289 26.7% 1129 26.0% 1045 27.8% 
80 and over 393 13.7% 479 11.3% 454 11.0% 394 10.4% 
missing  2 15.4% 2 9.1% 4 11.1% 1 4.0% 
Gender N(%), male 1473 26.3% 1952 23.3% 1793 23.3% 1600 23.0% 
Female  856 23.3% 1113 21.3% 1017 20.6% 902 20.8% 
missing  0 
 
0 0.0% 0 0.0% 0 0.0% 
Deprivation N(%) 
 1 (Least) 293 22.4% 453 22.6% 474 23.8% 457 25.2% 
2 414 25.6% 561 22.9% 506 21.6% 478 22.5% 
3 455 24.8% 603 22.6% 579 23.0% 494 22.8% 
4 514 25.6% 652 22.2% 578 22.4% 487 20.9% 
5 (Most) 632 26.7% 762 23.0% 651 21.8% 564 22.0% 
missing  21 16.7% 34 13.3% 22 10.3% 22 7.6% 
Co-morbidities N (%) 
 0 1595 23.5% 1936 20.4% 1580 20.2% 1247 19.6% 
1 544 29.9% 817 27.3% 866 26.4% 815 26.2% 
2 148 30.6% 233 27.3% 268 24.8% 316 25.9% 
3 or more 42 23.0% 79 27.3% 96 20.6% 124 20.7% 
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Table 2: Adjusted odds ratios for annual changes in the postoperative outcomes between April 2003 and 
March 2014, after accounting for patient characteristics and changes in the organisation of services.   
 
 Surgical outcome Unadjusted OR 
(95% CI) for 
average annual 
changes 
OR (95% CI) after 
adjusting for 
patient 
characteristics 
OR (95% CI) after 
adjusting for patient 
characteristics, trust 
volume and time to 
surgery 
30 day mortality  0.89 (0.87,0.91)a 0.87 (0.85,0.89)a 0.89 (0.87,0.91)a 
90 day mortality  0.90 (0.89,0.92)a 0.89 (0.87,0.90)a 0.90 (0.89,0.92)a 
1  year mortality  0.94 (0.93,0.95)a 0.93 (0.92,0.94)a 0.94 (0.92,0.95)a 
 
a p<0.001 
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Figure 1: Annual numbers of English NHS trusts performing surgery and the median volume of patients per 
trust between 1 April 2003 and 31 March 2014. Procedures are grouped by financial year (2003 = April 
2003 – March 2004).  
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Figure 2: Unadjusted rates of 30 day, 90 day and 1 year postoperative mortality between April 2003 and 
March 2014. Procedures are grouped by financial year (April – March) and are shown with 95% confidence 
intervals. 
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Figure 3: Partially and fully adjusted annual postoperative 90-day mortality for patients with oesophago-
gastric cancer having  curative e surgery between April 2003 and March 2014. Procedures are grouped by 
financial year (April – March) 
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Appendix :  
 
Table 1 Patients diagnosed and undergoing O-G cancer surgery and changes in NHS trust and consultant volume between 2003 
and 2014 
Year  2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 
No. patients undergoing 
O-G resection per year 
2974 2671 2634 2744 2631 2731 2542 2640 2565 2614 2459 
Median annual volume 
of patients / NHS trust 
21 22 22 29.5 30 43 45 54 56 58 55 
Median annual volume 
of patients / consultanta  
NAb NAb 11 13 12 15 15 14 14 15 14 
Number of 
consultants per 
NHS trusta 
1 or 2 NAb NAb 62 48 34 28 17 11 5 5 7 
3 NAb NAb 21 21 20 14 16 18 19 16 17 
4 + NAb NAb 10 11 15 14 17 19 19 21 21 
 
aMedian consultant volume and median patient per consultant were calculated after excluding those consultants who had 1 patient 
in a year  
bDetails of anonymised consultant data became available on HES in financial year 2005-06 
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Figure A Histograms of time to surgery in 2003/4 and 2013/14 
 
 
 
 
Caption Figure B: The distribution of time to surgery at the patient level shows that the majority of patients 
were operated on before 100 days in 2003 whereas in 2013 bimodal distribution is seen, with one group of 
patients operated on before 100 days and another group after 100 days The change in the distribution is 
consistent with the introduction of neoadjuvant chemotherapy in the treatment of O-G cancer patients during 
the time period of the analysis. The bimodal distribution suggests that the first group of patients goes straight 
to surgery after diagnosis, while the second group undergoes chemotherapy before proceeding to surgery.  
 
 
 
Figure B  Number of procedures per year in NHS trusts categories by the annual volume. Procedures are 
grouped by financial year (April – March). 
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